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Accepted 23 May 2012AbstractObjective: To design a functional, patient-centered model of patient complexity with practical applicability to analytic design and clin-
ical practice. Existing literature on patient complexity has mainly identified its components descriptively and in isolation, lacking clarity as
to their combined functions in disrupting care or to how complexity changes over time.
Study Design and Setting: The authors developed a cumulative complexity model, which integrates existing literature and emphasizes
how clinical and social factors accumulate and interact to complicate patient care. A narrative literature review is used to explicate the
model.
Results: The model emphasizes a core, patient-level mechanism whereby complicating factors impact care and outcomes: the balance
between patient workload of demands and patient capacity to address demands. Workload encompasses the demands on the patient’s time
and energy, including demands of treatment, self-care, and life in general. Capacity concerns ability to handle work (e.g., functional mor-
bidity, financial/social resources, literacy). Workload-capacity imbalances comprise the mechanism driving patient complexity. Treatment
and illness burdens serve as feedback loops, linking negative outcomes to further imbalances, such that complexity may accumulate over
time.
Conclusion: With its components largely supported by existing literature, the model has implications for analytic design, clinical
epidemiology, and clinical practice.
 2012 Elsevier Inc.
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Multimorbidity and chronic conditions are increasingly
prevalent, exacting high costs in terms of resources and out-
comes [1e5]. Social and environmental factors, also, con-
tinue to disrupt access, utilization, and self-care [6e8].
Consequently, there is a growing interest in studying patient
complexity as a way of understanding these dilemmas
[5,9e12]. However, prior conceptual work has yielded
mainly descriptive explanations with limited practical ap-
plicability, and most empirical studies on patient complex-
ity have lacked rigor and comprehensiveness [11].
We propose a model of patient complexity that integrates
extant approaches and improves clarity and applicability by
emphasizing functional mechanisms of complexity at the
level of the patient. This practical, patient-centered model* Corresponding author. Tel.: 507-266-1832; fax: 507-538-0850.
E-mail address: shippee.nathan@mayo.edu (N.D. Shippee).
0895-4356  2012 Elsevier Inc.
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Open access under CC BY-NC-ND license.is intended to guide improvements in the analysis and evalu-
ation of patient complexity and promote innovative care de-
livery for complex patients. In the following sections, we
(1) outline the model, (2) review existing literature in de-
scribing its components, and (3) discuss its implications for
analytic design, clinical epidemiology, and practice.1.1. A cumulative model of patient complexity
Complexity is inherently difficult to define, measure, or
predict [11e15], which creates challenges for analysis and
problem solving [16]. To get past this, we functionally de-
fine patient complexity as a dynamic state in which the per-
sonal, social, and clinical aspects of the patient’s experience
operate as complicating factors. We believe these factors
appear and accumulate over time, interacting with each
other in emergent, and even cyclical, ways. Our focus dif-
fers from work on complex interventions (which empha-
sizes organizational/systems processes and intervention
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 The authors outline a model of patient complexity
that focuses on the balance between patient work-
load of demands and patient capacity.
 Patient workload-capacity imbalances are identi-
fied as the central mechanism driving patient
complexityda mechanism that is also affected by
intensified treatment burden and worsened illness
burden over time.
 This model’s patient-centered, functional design
makes it more amenable to testing and application
than previous models, and offers a heuristic frame-
work that is generalizable to numerous clinical and
social circumstances.
 This paper indicates the need for cohesive, model-
driven analyses that incorporate sufficient method-
ological and substantive rigor in studying patient
complexity.
design) and complex outcomes (which focuses more on bi-
ological/chemical processes). Although patient complexity
may be evaluated via complex outcomes, and addressed
through complex interventions, we emphasize care deliv-
ery, self-care, and health at the level of the patient.
Existing literature has identified several components of
patient complexity, including clinical complications such
as chronicity and comorbidity [17e19]; burdensome treat-
ment and self-care regimens [20e22]; or environmental
and social factors that influence access, use, self-care, and
health [23e28]. Patients exist at the intersection of social,
personal, and clinical circumstances [10], and so they
may face multiple complicating factors [3,29e31].
However, conceptual literature remains focused on un-
derstanding complexity factors vis-a-vis their forms (clini-
cal, socioeconomic, or cultural), rather than their functions
in complicating care, a descriptive approach, which pro-
vides little analytic guidance. Perhaps reflecting this limita-
tion, research has rarely comprehensively examined how
combinations of complications interact to impact patients
[11,31], which inhibits researchers’ ability to track the clin-
ical epidemiology of patient complexity or design practice
interventions. Furthermore, authors have not emphasized
how individuals adapt, or succumb, to complexity over
time, which omits the accumulation of complicating factors
and the possibility of patient resilience.
We posit a patient-centered model of patient complexity
designed to address these issues by optimizing practical ap-
plicability. At the model’s core is a functional mechanism
by which medical, social, and personal factors translate into
the patient’s experience: namely, the balance between the
patient’s workload of demands (hereafter, patient workload)and patient capacity.Patient workload represents all the tasks
and responsibilities people grapple with on a day-to-day
basis. This encompasses everyday life demands plus the
responsibilities of patient-hood, including job/family, self-
care, clinical appointments, and other priorities [29e34].
Capacity signifies abilities, resources, or readiness to address
demands, including physical/mental functioning, socioeco-
nomic resources, social support, literacy, and attitudes/
beliefs [35e39]. Excessive workload or low capacity alone
might challenge patients, causing poor access, nonadher-
ence, low quality of life, or other problems. However, our
central argument is that it is an imbalance between the twod
a workload that exceeds capacitydwhich is the primary
driver of disruptions in care, self-care, and outcomes. Meet-
ing demands require some level of functioning; thus, limita-
tions on capacity will necessarily impact how patients take
part in, and experience, their lives and health care [40e42].
Additionally, facing burdensome demands with insufficient
abilities/resources to respond represents a stress process,
which may generate breakdowns in self-care and health
[43e46]. Moreover, patients whose demands exceed capac-
ity may experience care as burdensome, fragmented, or low
quality [47e49], whichmayworsen adherence, engagement,
quality of life, and health outcomes [50]. Fig. 1 displays this
general pattern.
Health ‘‘outcomes’’ often are not final endpointsd
especially in chronic caredbut rather have ongoing conse-
quences for patient care and well-being via their experiential
impacts on patients: namely, the burden of illness (BOI) (e.g.,
pain, functional morbidity [51e53]) and burden of treatment
(BOT) (intensification, added demands [33,54e56]). The
model incorporates these burdens as feedback loops, con-
necting poor outcomes with further erosion of patient capac-
ity (illness) and intensified demands (treatment), such that
patient complexity may build through cumulative cycles.
In the following section, we use a narrative literature re-
view to describe a cumulative model of patient complexity
(hereafter, the cumulative complexity model, Fig. 2)da
patient-centered framework that emphasizes the workload-
capacity balance and incorporates treatment and illness
burdens.1.2. Workload and capacity
Patient workload encompasses all the demands in patients’
lives, including everyday responsibilities alongside the de-
mands of patient-hooddall of which impact complexity
through their toll on patients’ time, effort, and attention. These
demands include job, family, travel/transportation, childcare,
scheduling and attending clinical appointments, preventive
care, self-education, self-care, taking medications, health
behaviors, caregiving, and paperwork [29,32,34,57e59].
Demandsmayvary in severalquantifiable attributes, including:
 Number of demands
 Their difficulty
As social and clinical complicating factors accumulate, they add to patient 
workload demands, reduce patient capacity, or both in various ways.
If patient workload expands and capacity dwindles, this creates an 
imbalance, as the patient passes his/her individual tipping point in one 
sphere of life or another and becomes overburdened, incapable of carrying 
out all the required tasks
This imbalance disrupts patterns of access, utilization, and the routine of 
self-care, influencing how patients make sense of, participate in, achieve, 
and monitor personal health outcomes—and leading to unplanned 
prioritization and unaddressed demands.
Workload-capacity imbalances may also persist and strengthen over time, 
as demands create stress, fatigue begets forgetfulness, and unfinished 
work piles up, leading to even further challenges and overburden. 
1
2
3
4
Fig. 1. Accumulation of patient workload demands and patient capacity factors.
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Work on comorbidity [17] is informative here: demands
may be concordant (e.g., monitoring a sick spousewhile
makingphone calls), ordiscordant (jobhours vs. clinical
appointments).
Some patients persevere despite tremendous workloads;
others falter even when relatively unencumbered. Accord-
ingly, themodel incorporates patient capacity, which denotes
the resources and limitations affecting patients’ ability or
readiness to do work, such as mental/physical functioning
[8,36,60e62]; unpleasant symptoms such as incontinence,
psoriasis, or insomnia [63e65]; pain, stress, or fatigue
[66e68]; and even problems secondary to the distinguishing
features of a diseasedfor instance, the nonmotor complica-
tions of Parkinson’s disease include genitourinary symptoms
and depression [69]. Capacity also encompasses socioeco-
nomic and psychological resources, literacy, language, and
social support [26,29,35,70e72]. Disease and social factors
may interact; for instance, nonvisible symptoms may fail to
elicit empathy, legitimization, or social support [73e76], just
when patients need it most. Attitudes and beliefs about health
care [10,32] also shape individuals’ readiness to perform
patient-related work. Measurable attributes of capacity in-
clude the following:
 Amount/magnitude (e.g., greater/lesser symptoms,
finances, or social support); Controllability (some factors, such as literacy, are
more responsive to personal efforts than others, such
as pain);
 Extensiveness or scope of impact (symptomsmay have
limited or widespread effects on functioning, self-
efficacy may be global or domain specific [77], etc.).1.3. Workloadecapacity interactions
Patient workload and capacity are intertwined (path a),
such that each affects the other. For instance, mental health
disorders reduce capacity through functional morbidity
[36,78e80], but also entail additional work in help seeking,
appointments, or taking medications [81e83]. Likewise, de-
manding workloads, as in caregiving, may reduce capacity
because of fatigue [84]. Analytically, this may confound
causal effects and interactions: analyses may require disen-
tangling ‘‘chicken-or-the-egg’’ questions in chronic disease
management, nonlinear fluctuations in complicating factors,
or situational tipping points. Given these complexities, mul-
tiple interactions may shape patient demands, capacity, and
the interplay between them (Fig. 3). Operationalizations will
differ depending on the study, but the extent to which these
interactions are optimized is likely central towhether patients
exhibit resiliency or worsened care and outcomes.
Beyond the aforementionedattributesof demands (number/
difficulty/fit), how patients prioritize based on time or other
Burden of illness (h)
Burden of treatment (g)
Patient capacity
*Examples: 
Physical/mental functioning, Pain, 
Symptoms, Fatigue, Finances, 
Literacy, Social support 
*Attributes of capacity factors:
Amount, Controllability, Extensiveness
Patient workload of demands
*Examples:
Job, Family, Self-care, Testing, 
Scheduling/attending appointments, 
Transportation, Paperwork
*Attributes of workload demands:
Number, Difficulty, Fit 
a
c
b
Access, Utilization, Self-care
d
Outcomes
e
f
Fig. 2. The cumulative complexity model.
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them more manageable, may be crucial in balancing work-
loads [17,85]. Likewise, how patients mobilize resources
[86], or coordinate resources, limitations, and their environ-
ments [87] while adapting to demands, will shape how capac-
ity manifests. Finally, the ways in which patients improvise in
these processes [88], routinize them into daily life [89,90], and
the timing with which they match resources to demands, are
vital yet virtually unexplored processes shaping care and
outcomes.Patient workload
Internal interactions: Prioritization, Synchronization
Patient capacity
Internal Interactions: Mobilization, Coordination 
Workload-capacity interactions
Improvisation, Routinization, Timing
Fig. 3. Interaction processes between patient workload-related and
patient capacity-related factors.1.4. Access, utilization, and self-care: paths b and c
Workload and capacity both affect patients’ experiences
with care and self-management. Time and effortdas impacted
by demands surrounding polypharmacy, transportation
difficulties, planning/scheduling, job, family, etc. [29,57,
91e93]dare central in determiningwhether and how patients
will effectively access, use, and enact care (Fig. 2, path b).
Interventions to improve medication adherencedincluding
loweringdosing frequencyor providing remindersdhave sup-
ported the usefulness of reducing or helping manage patients’
medication demands [94e96], and government programs
have tried alleviating other demands, including transportation
assistance [97e99]. Thus, existing efforts generally have em-
phasized reducing workload and/or providing support (essen-
tially, bolstering capacity). Comparative effectiveness
examinations of these strategies would help optimize future
interventions.
Capacity also shapes patterns of care and self-management
(path c). Functionally limiting mental or physical conditions
(depression, in particular) have well-established associations
with access, self-care, and adherence [8,100e106]. However,
there is relatively sparse evidence on cumbersome ‘‘second-
ary’’symptoms, suchasblurred visionorgastrointestinal prob-
lems, especially concerning treatments for which they are not
side effects [107]. Additionally, language, literacy, and numer-
acy [41,57,108], and patients’ backgrounds and environment
[39], also shape their readiness to access and use care.
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access services, they also decrease quality of life, and so
may promote help seeking in seemingly contradictory pat-
terns. For instance, individuals with depression often do not
opportunely seek help for it [109e111], yet depression also
predicts higher utilization and costs [112e114]. In brief,
depressed individuals may use services that are ill suited
to their needs, exacerbated by a greater sensitivity to pain
and somatic symptoms [35,115e117]. Therefore, capacity
may be understood as disrupting effective care, rather than
simply reducing quantity of care per se.
Various multivariate relationships operate between paths
b and c. For example, demands may increase stress or depres-
sion, which in turn reduce energy and cognitive functioning,
leading to lower adherence (mediation). Alternatively, poor
mental health may render some individuals especially vulner-
able to heavy workloads (moderation). These and other rela-
tionships require careful testing, especially with longitudinal
data, before making causal judgments.1.5. Health outcomes: paths def
Workload and capacity may directly impact patient out-
comes (paths d and e), regardless of experiences with care.
This distinction highlights subtle but important causal pro-
cesses: some interventions improve health outcomes but
not adherence, and vice versa [94,118,119]. Workload’s ef-
fect on health (d ) may be mediated by capacity (e), though
little research exists on the subject. Demands such as family
responsibilities can affect self-rated health and psychoso-
matic symptoms, including trouble sleeping [120]. However,
this may occur indirectly through capacity-related factors,
such as depression, stress, fatigue, and socioeconomic re-
sources, and their direct effects on hypertension, mortality,
and other outcomes [121e123].
Of course, disruptions in care are themselves well-known
contributors to poorer health (path f ). Access, self-care, and
unmet need are all associated with health, quality of life, and
mortality [7,124e127]; particularly direct examples include
highly active antiretroviral therapy [128e132] and postmyo-
cardial infarction care [133,134]. Unmet need stemming
from causes such as access problems, nontreatment, or
nonadherence can also contribute to clinical complications
[135e137] (e.g., low insulin adherence triggering poor gly-
cemic control and subsequent ketoacidosis [138]), further
driving costs, avoidable health events and hospitalizations,
and mortality [139e143].1.6. Patient burdens: paths g and h
Poor outcomes may lead clinicians to intensify treatment
[144,145], creating a BOT linking care and outcomes back
to increased demands. This is partially outlined in normaliza-
tion process theory [146,147], which focuses on the imple-
mentation of new demands into existing routines. Because of
BOT, patients whose workloads already exceed their capacitymay be expected to insert further demands into their lives, in-
creasing the potential for overburden.However, although poor
outcomes will, intuitively, lead to intensified care demands
[148,149], some studies find otherwise [144,150]. Such incon-
sistencymay reflect the lack of sufficient evidencewith proper
controls for the adherenceeintensification relationship
[42,151], which illustrates a need for more comprehensive
analyses of care following health outcomes, particularly in
chronic care.
If BOT is a feedback loop, then preventive care should
curb future demands: a benefit rarely addressed in existing
literature. For example, insufficient diabetes management
hinders glycemic control and can create complicationsd
complications that require escalating treatments and self-
care (in patients with reduced capacity, no less, given their
worsened health/functional status). Unfortunately, BOT’s
impact is elusive: clinicians have trouble recognizing non-
adherence [152], and may mistakenly raise doses rather
than address the underlying difficulties. Consequently, in-
tensified treatment to clinical targets, with little regard for
BOT, may prove unsustainable because overburdened pa-
tients may not adhere. Therefore, minimally disruptive
medicine [153], which accounts for patients’ finite time
and energy with careful attention to treatment demands,
is vital alongside evidence-based guidelines in caring for
complex patients.
Parallel to BOT is the BOI. Elements of BOIdthe as-
pects of poor health that impact patients’ functioning and
quality of life [51e53]dlink poor outcomes and/or disease
progression to further decreased capacity. Unlike strictly
clinical measures (e.g., lab numbers), BOI’s manifestation
in patients’ functioning and well-being may further disrupt
their ability to manage demands. Thus, BOI is a feedback
mechanism driving patient complexity through capacity
erosion. It also embodies the lost potential of unsuccessful
treatments and self-care, which impose workloads but fail
to improve symptoms or capacity. This may reflect resistant
diseases, inadequate dosing/adherence, or ineffective treat-
ment [154e156], but the consequences are the same: con-
tinued, capacity-related vulnerabilities.2. Implications
The cumulative complexity model integrates existing lit-
erature into a practical, patient-centered framework.With the
workload-capacity balance at its core, and by incorporating
patient burdens, the model emphasizes the longitudinal,
patient-level interplay of complicating factors. Here, we out-
line its implications for analytic design, clinical epidemiol-
ogy, and practice (see Fig. 4 for proposed approaches to
implementation).
2.1. Analytic design
First, this model indicates how to identify complicating
factors that remain understudied by asking questions about
John D. (67)
•Multiple chronic 
conditions
•Wife has 
dementia
•Tries to get out 
and walk for 
exercise
•Lives 25 miles 
from town
Administrative/Clinical 
Health conditions; activities of 
daily living; lab tests;  clinic 
visits; medications; specialties 
seen; demographics; coverage
Patient-reported
Self-efficacy; health literacy; 
mental/physical health; 
resilience; social support; 
inconvenience; personal 
priorities 
Imbalances via:
Patient-reported distress, 
fatigue, and overburden
Administrative missed/
rescheduled appointments, 
non-adherence
Measurement
Standard language and approach: Compare across 
studies and settings; generalize across 
circumstances/conditions
Tracking, assessment: Predictive value of indicators 
to define multidimensional profiles/taxonomies of 
patient complexity; prevalence of different complexity 
profiles; cut-points to trigger clinical review; algorithms 
Multidimensionality: Cluster analysis; latent class 
models; structural equation models; clinician ratings
Interactions: Mediation/moderation: conventional 
interaction terms; marginal effects
Longitudinal: Growth curves/latent growth curves; 
patterns of linear versus non-linear accumulation (or 
resilience); cycles linking outcomes to burdens
Analytic Design
Clinical Epidemiology
Decision support tool: Identify complicating factors 
with diagnostic screening questions
Care redesign: Minimally disruptive medicine to 
strategically prioritize care demands; integrate health 
care and community resources to support capacity
Clinical Practice
Fig. 4. Proposed implementation of model-based analyses, clinical research, and practice interventions.
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time, energy, and attention, and what is limiting their ability
to manage demands? As noted, understudied factors include
the capacity-limiting impacts of often-‘‘secondary’’ symp-
toms such as gastrointestinal problems, workload’s impact
on health (via stress processes vs. resultant poor health be-
haviors), and BOT. However, if factors interact to shape pa-
tient complexity (a key assertion here), then assessing them
singly is of limited usefulness.
A second, more relevant implication is that in highlighting
functional relationships, the model promotes investigations
into how complicating factors interact. Based on reasoning
and literature above, workload-capacity imbalances will
create compounded risks in care and outcomes. Operationali-
zations must be addressed empirically by each study individ-
ually, but Fig. 3 above outlines several interactions, and
previous literature on cumulative processes suggests other
possibilities. For instance, socioeconomic disadvantages
may have concurrent direct and indirect effects on care and
outcomes (e.g., inability to pay alongside chronic stress),
reflecting structural amplification [157]. Alternatively,
capacity-limiting circumstances may sensitize [158] patients,
leaving them especially vulnerable to heavy workloads. As-
certaining these processes could entail various methods, in-
cluding structural equation models, formal mediation/
moderation analyses, simulations, or qualitative approaches.
Third is the combination of BOT and BOI, particularly
for already-complex patients. Patients can integrate burdens
into their daily lives [146,159], but how do they experience
BOT alongside BOI and other factors? After all, comorbid-
ity, pent-up need, or other problems will likely create high
burdens on all sides [139,140,160,161]. Prior work has
highlighted the problem of balancing concurrent treatment
demands [17]; we propose studying how patients balanceself-care and functional limitations. Furthermore, what hap-
pens when asymptomatic but treatment-intensive condi-
tions (high BOT, low BOI) collide with bothersome but
clinically minor symptoms (low BOT, high BOI)ddo peo-
ple prioritize clinical targets or subjective comfort? Patients
may attempt, above all, to maintain workload-capacity bal-
ances (i.e., do whatever keeps them functioning from day to
day). If so, then studying patients with chronic conditions
entails assessing whether treatment demands fit within their
daily lives: disruptive tasks may be ignored.
A fourth implication is the cyclical, ongoing nature of
complexity. Patients may become more complex over time
because of accumulation and feedback between factors.
Thus, linking early workload-capacity imbalances to later
burdensdwhether through worsened symptoms, pent-up
demand, or intensificationdis essential in mapping health
and self-care. This is especially pertinent for patients with
chronic conditions, for whom fatigue, demands, and other
issues can have lifelong importance. Studying such patterns
requires longitudinal data and, for instance, growth curves
for assessing individual trajectories.
A final implication is the possibility of resilience. During
continued experiences with patient-hood over time, some in-
dividuals may be particularly successful at normalizing bur-
dens [33]. Literature elsewhere has identified some patterns
of resilience, including ‘‘desensitization’’ and ‘‘acquired im-
munity’’ [158,162], in which early adversity toughens indi-
viduals against future hardship (e.g., an early chronic
disease diagnosis may spark patient engagement). Resilience
also can be seen as an aspect of capacity: self-efficacy or
other psychological resources may help some patients resist
overburden. Finally, resilient adaptations may reflect pa-
tients’ success in optimizing the interactions outlined in
Fig. 3.
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The present model has implications for the clinical epide-
miology of patient complexity: it suggests an approach to the
measurement, evaluation, and tracking of patient complexity
itself as a dynamic state with ongoing clinical and personal
consequences. Currently, no common language or frame-
work exist for doing so, which prevents comprehensive esti-
mates and risk assessment. The cumulative complexity
model addresses this by providing a unifying language and
generalizable approach that capture the multidimensional
variability and accumulation potential of complexity.
Studying how complicating factors affect care and out-
comes would generate estimates of their predictive value
for prognostic/risk assessment of complex patients. Those
with the greatest analytic utility could then be combined
to efficiently assess patient complexity as multidimension-
ally, using approaches such as cluster analysis. This would
produce efficient, clinically relevant taxonomies of patient
complexity, based on common patient phenotypes (we cur-
rently have one such proposal under review). Studies could
then develop prevalence estimates of these phenotypes,
including estimates of their distributions across groups.
As evidence grows, researchers could exploit the re-
peated use of standard assessments and studies of prognos-
tic value to determine cut points for when combinations of
patient complexity will result in measurable problems for
care. This would, furthermore, facilitate development of
diagnostic criteria or decision trees/algorithms for manag-
ing complexity in practice.2.3. Clinical practice
Beyond the possibilities listed above, the proposed model
has immediate implications for clinical practice. Treatment
and self-care demands partially result from clinical action,
and are thus amenable to change. If care enlists multiple spe-
cialties or targets clinical outcomes without considering bur-
den, patients may become overwhelmed by fragmented,
demanding care [21]. Facing other demands and limitations,
they may resort to self-initiated prioritization rather than
alerting providers. Thus, there is a need to embed treatment
strategies into patients’ lives to minimize burden and ensure
adherenceda minimally disruptive medicine approach [153]
toward preventing workload-capacity imbalances.
Clinicians can begin by working with patients to identify
workload-capacity difficulties. As such, the model can inform
development of a decision-support tool to help ascertain prob-
lems during clinical encounters and suggest solutions for min-
imizing patient burdens, similar to other decision aids and
shared decision-making approaches [163,164].Complications
include finding the correct terminology: patients may dislike
notions of ‘‘burden’’ or limited ‘‘capacity.’’ However, such
a tool could improve communication, patient experiences,
and self-care, and uncover otherwise-missed complexity
within the limited clinical encounter timeframe.Patient-centered medical homes [160] represent one site
for improved workload-capacity balances in practice. Yet,
if coordinated care still necessitates intensive treatment and
self-care, practices will need to include capacity support
(via care managers or community services), or work to care-
fully minimize demands. Our team currently is developing
a model-based intervention (currently in prototype-testing
stages) to help reduce the footprint of health care in the lives
of patients with multiple chronic conditions. However, more
needs to be done in this area to ensure that providers and pa-
tients can meet the increasingly salient challenges of patient
complexity.3. Conclusions
This article proposes a patient-centered model of patient
complexity in which clinical and social factors accumulate
and interact to shape access, utilization, self-care, and
health. Integrating prior literature, this cumulative com-
plexity model emphasizes patient-level functions whereby
complicating factors influence outcomes: workload, capac-
ity, and treatment and illness burdens. This focus on func-
tion facilitates a cohesive, generalizable framework with
practical applicability. The model also suggests advances
in analytic design, clinical epidemiology, and practice.
This model is neither final nor static. It is meant to drive
empirical and practice-based applications, and therefore is
subject to clarification, falsification, and critique. More-
over, it cannot irrefutably specify all the methodological
decisions implied by its paths, because these will differ
for each study.
Overall, the cumulative complexity model is intended to
stimulate innovations in research and practice that respect
the clinical importance of workload-capacity imbalances.
This implies a need for improvement in areas from access
barriers to treatment burden. It also highlights the need to
move from disease-centered to patient-centered paradigms
in care delivery. As such, it speaks to a broad array of pa-
tient experiences and difficulties, and illustrates possibili-
ties for improved analysis and care in the patient-provider
interface and beyond.Acknowledgments
The authors have no conflicts of interest to report. This
project was funded in part by the Mayo Foundation for
Medical Education and Research.References
[1] Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and
complications of multiple chronic conditions in the elderly. Arch
Intern Med 2002;162:2269e76.
[2] Paez KA, Zhao L, Hwang W. Rising out-of-pocket spending for
chronic conditions: a ten-year trend. Health Aff 2009;28:15e25.
1048 N.D. Shippee et al. / Journal of Clinical Epidemiology 65 (2012) 1041e1051[3] Anderson GF. Medicare and chronic conditions. N Engl J Med
2005;353:305e9.
[4] Naessens JM, Leibson CL, Krishan I, Ballard DJ. Contribution of
a measure of disease complexity (COMPLEX) to prediction of out-
come and charges among hospitalized patients. Mayo Clin Proc
1992;67:1140e9.
[5] Taheri PA, Butz DA, Greenfield LJ. Paying a premium: how patient
complexity affects costs and profit margins. Ann Surg 1999;
229:807.
[6] Pollock DL, Rainer NE. Healthcare access: a review of major barriers
to health care services for women. Georgetown J Gend Law 2005;6:
825e58.
[7] Arora NK, Johnson P, Gustafson DH, McTavish F, Hawkins RP,
Pingree S. Barriers to information access, perceived health compe-
tence, and psychosocial health outcomes: test of a mediation model
in a breast cancer sample. Patient Educ Couns 2002;47:37e46.
[8] Kroll T, JonesGC, KehnM,NeriMT. Barriers and strategies affecting
the utilisation of primary preventive services for people with physical
disabilities: a qualitative inquiry. Health Soc Care Community
2006;14:284e93.
[9] Peek CJ, Baird MA, Coleman E. Primary care for patient complex-
ity, not only disease. Fam Syst Health 2009;27:287e302.
[10] Safford M, Allison J, Kiefe C. Patient complexity: more than
comorbidity. The vector model of complexity. J Gen Intern Med
2007;22:382e90.
[11] Whittle J, Bosworth H. Studying complexity is complex. J Gen
Intern Med 2007;22:379e81.
[12] Grant RW, Ashburner JM, Hong CC, Chang Y, Barry MJ, Atlas SJ.
Defining patient complexity from the primary care physician’s per-
spective: a cohort study. Ann Intern Med 2011;155:797e804.
[13] Plsek PE, Greenhalgh T. The challenge of complexity in health care.
BMJ 2001;323:625e8.
[14] Kurtz CF, Snowden DJ. The new dynamics of strategy: sense-making
in a complex and complicated world. IBM Syst J 2003;42:462e83.
[15] Nardi R, Scanelli G, Corrao S, Iori I, Mathieu G, Cataldi
Amatrian R. Co-morbidity does not reflect complexity in internal
medicine patients. Eur J Intern Med 2007;18:359e68.
[16] May C. A rational model for assessing and evaluating complex
interventions in health care. BMC Health Serv Res 2006;6:86.
[17] Piette JD, Kerr EA. The impact of comorbid chronic conditions on
diabetes care. Diabetes Care 2006;29:725e31.
[18] Piette JD, Richardson C, Valenstein M. Addressing the needs of
patients with multiple chronic illnesses: the case of diabetes and
depression. Am J Manag Care 2004;10:152e62.
[19] Turner BJ, Cuttler L. The complexity of measuring clinical com-
plexity. Ann Intern Med 2011;155:851e2.
[20] DeRubertis BG, Pierce M, Chaer RA, Rhee SJ, Benjeloun R,
Ryer EJ, et al. Lesion severity and treatment complexity are associ-
ated with outcome after percutaneous infra-inguinal intervention. J
Vasc Surg 2007;46:709e16.
[21] Bohlen K, Scoville E, Shippee ND, May CR, Montori VM. Over-
whelmed patients: a videographic analysis of how patients with type
2 diabetes and clinicians articulate and address treatment burden
during clinical encounters. Diabetes Care 2012;35:47e9.
[22] Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS. Descrip-
tions of barriers to self-care by persons with comorbid chronic dis-
eases. Ann Fam Med 2003;1:15e21.
[23] Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR. Race
and trust in the health care system. Public Health Rep 2003;118:
358e65.
[24] Friedman E. Money isn’t everything: nonfinancial barriers to access.
JAMA 1994;271:1535e8.
[25] Johnson SK. Hmong health beliefs and experiences in the western
health care system. J Transcult Nurs 2002;13:126e32.
[26] Williams MV, Parker RM, Baker DW, Parikh NS, Pitkin K,
Coates WC, et al. Inadequate functional health literacy among
patients at two public hospitals. JAMA 1995;274:1677e82.[27] Love D, Lindquist P. The geographical accessibility of hospitals to
the aged: a geographic information systems analysis within Illinois.
Health Serv Res 1995;29:629e51.
[28] Brown AF, Ettner SL, Piette J, Weinberger M, Gregg E, Shapiro MF,
et al. Socioeconomic position and health among persons with diabe-
tes mellitus: a conceptual framework and review of the literature.
Epidemiol Rev 2004;26:63e77.
[29] Ahmed SM, Lemkau JP, Nealeigh N, Mann B. Barriers to healthcare
access in a non-elderly urban poor American population. Health Soc
Care Community 2001;9:445e53.
[30] Kullgren JT, McLaughlin CG. Beyond affordability: the impact of
nonfinancial barriers on access for uninsured adults in three diverse
communities. J Community Health 2010;35:240e8.
[31] Shi L, Stevens GD. Vulnerability and unmet health care needs.
J Gen Intern Med 2005;20:148e54.
[32] Davis K, Collins KS, Schoen C, Morris C. Choice matters: enroll-
ees’ views of their health plans. Health Aff 1995;14:99e112.
[33] Gallacher K, May CR, Montori VM, Mair FS. Understanding pa-
tients’ experiences of treatment burden in chronic heart failure using
normalization process theory. Ann Fam Med 2011;9:235e43.
[34] Joseph AE, Hallman BC. Over the hill and far away: distance as
a barrier to the provision of assistance to elderly relatives. Soc Sci
Med 1998;46:631e9.
[35] Bair MJ, Matthias MS, Nyland KA, Huffman MA, Stubbs DL,
Kroenke K, et al. Barriers and facilitators to chronic pain self-
management: a qualitative study of primary care patients with comor-
bid musculoskeletal pain and depression. PainMed 2009;10:1280e90.
[36] Burdick KE, Gunawardane N, Goldberg JF, Halperin JM, Garno JL,
Malhotra AK. Attention and psychomotor functioning in bipolar
depression. Psychiatry Res 2009;166:192e200.
[37] Hartnett ME, Key IJ, Loyacano NM, Horswell RL, DeSalvo KB.
Perceived barriers to diabetic eye care: qualitative study of patients
and physicians. Arch Ophthalmol 2005;123:387e91.
[38] Siegel K, Raveis VH, Houts P, Mor V. Caregiver burden and unmet
patient needs. Cancer 1991;68:1131e40.
[39] Mackenzie CS, Gekoski WL, Knox VJ. Age, gender, and the under-
utilization of mental health services: the influence of help-seeking
attitudes. Aging Ment Health 2006;10:574e82.
[40] McKellar JD, Humphreys K, Piette JD. Depression increases diabe-
tes symptoms by complicating patients’ self-care adherence. Diabe-
tes Educ 2004;30:485e92.
[41] Kalichman SC, Ramachandran B, Catz S. Adherence to combina-
tion antiretroviral therapies in HIV patients of low health literacy.
J Gen Intern Med 1999;14:267e73.
[42] Katon W, Russo J, Lin EHB, Heckbert SR, Karter AJ, Williams LH,
et al. Diabetes and poor disease control: is comorbid depression as-
sociated with poor medication adherence or lack of treatment inten-
sification? Psychosom Med 2009;71:965e72.
[43] Gallant MP, Connell CM. Predictors of decreased self-care among
spouse caregivers of older adults with dementing illnesses. J Aging
Health 1997;9:373e95.
[44] Norbeck JS, Tilden VP. Life stress, social support, and emotional
disequilibrium in complications of pregnancy: a prospective, multi-
variate study. J Health Soc Behav 1983;24:30e46.
[45] Murphy DA, Greenwell L, Hoffman D. Factors associated with anti-
retroviral adherence among HIV-infected women with children.
Women Health 2002;36:97e111.
[46] Son J, Erno A, Shea DG, Femia EE, Zarit SH, Parris Stephens MA.
The caregiver stress process and health outcomes. J Aging Health
2007;19:871e87.
[47] Shi L. Type of health insurance and the quality of primary care
experience. Am J Public Health 2000;90:1848e55.
[48] Shi L. Experience of primary care by racial and ethnic groups in the
United States. Med Care 1999;37:1068e77.
[49] Oberst MT, Hughes SH, Chang AS, McCubbin MA. Self-care bur-
den, stress appraisal, and mood among persons receiving radiother-
apy. Cancer Nurs 1991;14:71e8.
1049N.D. Shippee et al. / Journal of Clinical Epidemiology 65 (2012) 1041e1051[50] Beach MC, Keruly J, Moore RD. Is the quality of the patient-
provider relationship associated with better adherence and health
outcomes for patients with HIV? J Gen Intern Med 2006;21:661e5.
[51] McGuire T, Wells KB, Bruce ML, Miranda J, Scheffler R, DurhamM,
et al. Burden of illness. Ment Health Serv Res 2002;4:179e85.
[52] Waern M, Rubenowitz E, Runeson B, Skoog I, Wilhelmson K,
Allebeck P. Burden of illness and suicide in elderly people: case-
control study. BMJ 2002;324:1355.
[53] Gore M, Brandenburg NA, Hoffman DL, Tai K-S, Stacey B. Burden
of illness in painful diabetic peripheral neuropathy: the patients’
perspectives. J Pain 2006;7:892e900.
[54] Oude Elberink JNG, van der Heide S, Guyatt GH, Dubois AEJ.
Analysis of the burden of treatment in patients receiving an EpiPen
for yellow jacket anaphylaxis. J Allergy Clin Immunol 2006;118:
699e704.
[55] Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Stranne J,
et al. The excess burden of side-effects from treatment in men allo-
cated to screening for prostate cancer. The G€oteborg randomised
population-based prostate cancer screening trial. Eur J Cancer
2011;47:545e53.
[56] Anderson RT, Girman CJ, Pawaskar MD, Camacho FT, Calles J,
Kelly WS, et al. Diabetes medication satisfaction tool. Diabetes
Care 2009;32:51e3.
[57] Flores G, Abreu M, Olivar MA, Kastner B. Access barriers to health
care for Latino children. Arch Pediatr Adolesc Med 1998;152:
1119e25.
[58] Yang S, Zarr RL, Kass-Hout TA, Kourosh A, Kelly NR. Transpor-
tation barriers to accessing health care for urban children. J Health
Care Poor Underserved 2006;17:928e43.
[59] Kelly SE, Binkley CJ, Neace WP, Gale BS. Barriers to care-seeking
for children’s oral health among low-income caregivers. Am J Pub-
lic Health 2005;95:1345e51.
[60] Saunders DG. Posttraumatic stress symptom profiles of battered
women: a comparison of survivors in two settings. Violence Vict
1994;9:31e44.
[61] Huber SJ, Paulson GW, Shuttleworth EC. Relationship of motor
symptoms, intellectual impairment, and depression in Parkinson’s
disease. J Neurol Neurosurg Psychiatry 1988;51:855e8.
[62] Gregg EW, Mangione CM, Cauley JA, Thompson TJ, Schwartz AV,
Ensrud KE, et al. Diabetes and incidence of functional disability in
older women. Diabetes Care 2002;25:61e7.
[63] Hilton P, Stanton SL. Urethral pressure measurement by microtrans-
ducer: the results in symptom-free women and in those with genuine
stress incontinence. Br J Obstet Gynaecol 1983;90:919e33.
[64] Simon G, VonKorff M. Prevalence, burden, and treatment of insom-
nia in primary care. Am J Psychiatry 1997;154:1417e23.
[65] Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis
is common, carries a substantial burden even when not extensive,
and is associated with widespread treatment dissatisfaction. J Inves-
tig Dermatol Symp Proc 2004;9:136e9.
[66] Bennett EJ, Tennant CC, Piesse C, Badcock C-A, Kellow JE. Level
of chronic life stress predicts clinical outcome in irritable bowel
syndrome. Gut 1998;43:256e61.
[67] Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG,
Komaroff A, Group. ICFSS. The chronic fatigue syndrome: a com-
prehensive approach to its definition and study. Ann Intern Med
1994;121:953e9.
[68] Swain MG. Fatigue in chronic disease. Clin Sci 2000;99:1e8.
[69] Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of
Parkinson’s disease: diagnosis and management. Lancet Neurol
2006;5:235e45.
[70] Glasgow RE, Toobert DJ, Gillette CD. Psychosocial barriers to
diabetes self-management and quality of life. Diabetes Spectr
2001;14:33e41.
[71] DeVoe JE, Baez A, Angier H, Krois L, Edlund C, Carney PA. Insur-
ance þ access? Health care: typology of barriers to health care
access for low-income families. Ann Fam Med 2007;5:511e8.[72] Timmins CL. The impact of language barriers on the health care
of Latinos in the United States: a review of the literature and
guidelines for practice. J Midwifery Womens Health 2002;47:
80e96.
[73] Glenton C. Chronic back pain sufferersdstriving for the sick role.
Soc Sci Med 2003;57:2243e52.
[74] Richardson JC, Ong BN, Sim J. Experiencing chronic widespread
pain in a family context: giving and receiving practical and emo-
tional support. Sociol Health Illn 2007;29:347e65.
[75] Stone SD. Reactions to invisible disability: the experiences of young
women survivors of hemorrhagic stroke. Disabil Rehabil 2005;27:
293e304.
[76] Parsons T. The Social System. London, UK: Taylor & Francis; 1991
[1951].
[77] Leganger A, Kraft P, R/ysamb E. Perceived self-efficacy in health
behaviour research: conceptualisation, measurement and correlates.
Psychol Health 2000;15:51e69.
[78] Wagner HR, Burns BJ, Broadhead WE, Yarnall KSH, Sigmon A,
Gaynes BN. Minor depression in family practice: functional mor-
bidity, co-morbidity, service utilization and outcomes. Psychol
Med 2000;30:1377e90.
[79] Shippee N, Shah N, Williams M, Moriarty J, Frye M, Ziegenfuss J.
Differences in demographic composition and inwork, social, and func-
tional limitations among the populations with unipolar depression and
bipolardisorder: results fromanationally representative sample.Health
Qual Life Outcomes 2011;9:90.
[80] Borkowska A, Rybakowski JK. Neuropsychological frontal lobe
tests indicate that bipolar depressed patients are more impaired than
unipolar. Bipolar Disord 2001;3:88e94.
[81] Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB,
Bersoff-Matcha S, et al. Effects of depression and selective seroto-
nin reuptake inhibitor use on adherence to highly active antiretrovi-
ral therapy and on clinical outcomes in HIV-infected patients.
J Acquir Immune Defic Syndr 2008;47:384e90.
[82] Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM. Impact of
antidepressant drug adherence on comorbid medication use and
resource utilization. Arch Intern Med 2005;165:2497e503.
[83] Lin EHB, Katon W, Rutter C, Simon GE, Ludman EJ, Von Korff M,
et al. Effects of enhanced depression treatment on diabetes self-care.
Ann Fam Med 2006;4:46e53.
[84] Clark PC. Effects of individual and family hardiness on caregiver
depression and fatigue. Res Nurs Health 2002;25:37e48.
[85] Golin C, Isasi F, Bontempi JB, Eng E. Secret pills: HIV-positive pa-
tients’ experiences taking antiretroviral therapy in North Carolina.
AIDS Educ Prev 2002;14:318e29.
[86] Gibson CH. A concept analysis of empowerment. J Adv Nurs
1991;16:354e61.
[87] Riegel B, Carlson B. Facilitators and barriers to heart failure self-
care. Patient Educ Couns 2002;46:287e95.
[88] Wdowik MJ, Kendall PA, Harris MA. College students with dia-
betes: using focus groups and interviews to determine psychoso-
cial issues and barriers to control. Diabetes Educ 1997;23:
558e62.
[89] Lundman B, Norberg A. Coping strategies in people with insulin-
dependent diabetes mellitus. Diabetes Educ 1993;19:198e204.
[90] Roberts KJ. Barriers to and facilitators of HIV-positive patients’
adherence to antiretroviral treatment regimens. AIDS Patient Care
STDS 2000;14:155e68.
[91] Diamant AL, Hays RD, Morales LS, Ford W, Calmes D, Asch S,
et al. Delays and unmet need for health care among adult primary
care patients in a restructured urban public health system. Am J
Public Health 2004;94:783e9.
[92] SteinM,Crystal S,CunninghamW,AnanthanarayananA,AndersenR,
Turner B, et al. Delays in seeking HIV care due to competing caregiver
responsibilities. Am J Public Health 2000;90:1138e40.
[93] Emslie-Smith A, Dowall J, Morris A. The problem of polypharmacy
in type 2 diabetes. Br J Diabetes Vasc Dis 2003;3:54e6.
1050 N.D. Shippee et al. / Journal of Clinical Epidemiology 65 (2012) 1041e1051[94] McDonald HP, Garg AX, Haynes RB. Interventions to enhance pa-
tient adherence to medication prescriptions: scientific review. JAMA
2002;288:2868e79.
[95] Kripalani S, Yao X, Haynes RB. Interventions to enhance medica-
tion adherence in chronic medical conditions: a systematic review.
Arch Intern Med 2007;167:540e9.
[96] Claxton AJ, Cramer J, Pierce C. A systematic review of the associ-
ations between dose regimens and medication compliance. Clin
Ther 2001;23:1296e310.
[97] Minnesota Department of Human Services. MNET: early signs of
success. DHS report 051670. St. Paul, MN: State of Minnesota
Department of Human Services; 2005. Available at: http://www.
dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs_
id_051670.pdf. Accessed June 18, 2012.
[98] Pennsylvania Department of Public Welfare. Medical assistance trans-
portation program. 2012. Available at http://matp.pa.gov/. Accessed
June 18, 2012.
[99] Kentucky Division of Family Support. Medical support and benefits
branch. 2012. Available at http://chfs.ky.gov/dcbs/dfs/. Accessed
June 18, 2012.
[100] Torres-Harding SR, Jason LA, Taylor RR. Fatigue severity, attribu-
tions, medical utilization, and symptoms in persons with chronic
fatigue. J Behav Med 2002;25:99e113.
[101] Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L,
et al. Depressive symptoms, neurocognitive impairment, and adher-
ence to highly active antiretroviral therapy among HIV-infected per-
sons. Psychosomatics 2004;45:394e402.
[102] Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G.
Muscle weakness is related to utilization of health care resources
in COPD patients. Eur Respir J 1997;10:417e23.
[103] Morgan AL, Masoudi FA, Havranek EP, Jones PG, Peterson PN,
et al. Difficulty taking medications, depression, and health status
in heart failure patients. J Card Fail 2006;12:54e60.
[104] Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L,
Wittenberg E, et al. Depression, self-care, and medication adherence
in type 2 diabetes. Diabetes Care 2007;30:2222e7.
[105] Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL.
Depression is an important contributor to low medication adherence
in hemodialyzed patients and transplant recipients. Kidney Int
2009;75:1223e9.
[106] Druss BG, Rask K, Katon WJ. Major depression, depression treat-
ment and quality of primary medical care. Gen Hosp Psychiatry
2008;30:20e5.
[107] Florez H, Luo J, Castillo-Florez S, Mitsi G, Hanna J, Tamariz L,
et al. Impact of metformin-induced gastrointestinal symptoms on
quality of life and adherence in patients with type 2 diabetes. Post-
grad Med 2010;122:112e20.
[108] Lindau ST, Tomori C, McCarville MA, Bennett CL. Improving rates
of cervical cancer screening and pap smear follow-up for low-
income women with limited health literacy. Cancer Invest
2001;19:316e23.
[109] Coyle JT, Pine DS, Charney DS, Lewis L, Nemeroff CB,
Carlson GA, et al. Depression and bipolar support alliance consen-
sus statement on the unmet needs in diagnosis and treatment of
mood disorders in children and adolescents. J Am Acad Child
Adolesc Psychiatry 2003;42:1494e503.
[110] Wisdom JP, Clarke GN, Green CA. What teens want: barriers to
seeking care for depression. Adm Policy Ment Health 2006;33:
133e45.
[111] Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A, et al.
Major depression in outpatients attending a regional cancer centre:
screening and unmet treatment needs. Br J Cancer 2004;90:
314e20.
[112] Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ,
et al. The impact of treatment-resistant depression on health care
utilization and costs. J Clin Psychiatry 2002;63:963e71.[113] Dennis CL. Influence of depressive symptomatology on maternal
health service utilization and general health. Archiv Womens Ment
Health 2004;7:183e91.
[114] Luber MP, Meyers BS, Williams-Russo PG, Hollenberg JP,
DiDomenico TN, Charlson ME, et al. Depression and service utili-
zation in elderly primary care patients. Am J Geriatr Psychiatry
2001;9:169e76.
[115] Alvarenga ME, Caniato RN, Mauritz A, Braun A, Aljeesh Y,
Baune BT. Health service utilization in patients with major depres-
sion and co-morbid pain. Psychiatry Clin Neurosci 2009;63:101e6.
[116] Lepine JP, Briley M. The epidemiology of pain in depression. Hum
Psychopharmacol 2004;19:S3e7.
[117] Katon W, Berg AO, Robins AJ, Risse S. Depressionemedical utili-
zation and somatization. West J Med 1986;144:564e8.
[118] Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N,
Mitchell AJ, et al. Depression screening and patient outcomes in
cardiovascular care: a systematic review. JAMA 2008;300:
2161e71.
[119] Haynes BR, McKibbon AK, Ronak K. Systematic review of rando-
mised trials of interventions to assist patients to follow prescriptions
for medications. Lancet 1996;348:383e6.
[120] Artazcoz L, Artieda L, Borrell C, Cortes I, Benach J, Garcıa V.
Combining job and family demands and being healthy. Eur J Public
Health 2004;14:43e8.
[121] Malmo RB, Shagass C. Physiologic study of symptom mechanisms
in psychiatric patients under stress. Psychosom Med 1949;11:25e9.
[122] Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH,
Cuffe MS, et al. Relationship of depression to increased risk of mor-
tality and rehospitalization in patients with congestive heart failure.
Arch Intern Med 2001;161:1849e56.
[123] Peyrot M, McMurry JF Jr, Kruger DF. A biopsychosocial model of
glycemic control in diabetes: stress, coping and regimen adherence.
J Health Soc Behav 1999;40:141e58.
[124] Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM,
Kitabchi AE. Hyperglycemia: an independent marker of in-hospital
mortality in patients with undiagnosed diabetes. J Clin Endocrinol
Metab 2002;87:978e82.
[125] DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adher-
ence and medical treatment outcomes: a meta-analysis. Med Care
2002;40:794e811.
[126] Pladevall M,Williams LK, Potts LA, Divine G, Xi H, Elston Lafata J.
Clinical outcomes and adherence to medications measured by claims
data in patients with diabetes. Diabetes Care 2004;27:2800e5.
[127] McDermott MM, Schmitt B, Wallner E. Impact of medication non-
adherence on coronary heart disease outcomes: a critical review.
Arch Intern Med 1997;157:1921e9.
[128] Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The con-
sistency of adherence to antiretroviral therapy predicts biologic out-
comes for human immunodeficiency virus-infected persons in
clinical trials. Clin Infect Dis 2002;34:1115e21.
[129] Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA,
Beall GN, et al, Group tCCT. The value of patient-reported adher-
ence to antiretroviral therapy in predicting virologic and immuno-
logic response. AIDS 1999;13:1099e107.
[130] McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH,
Nicolau DP. Adherence to highly active antiretroviral therapy pre-
dicts virologic outcome at an inner-city human immunodeficiency
virus clinic. Clin Infect Dis 2001;33:700e5.
[131] Gill CJ, Griffith JL, Jacobson D, Skinner S, Gorbach SL, Wilson IB.
Relationship of HIV viral loads, CD4 counts, and HAART use to
health-related quality of life. J Acquir Immune Defic Syndr 2002;
30:485e92.
[132] Ammassari A, Antinori A, Cozzi-Lepri A, Trotta MP, Nasti G,
Ridolfo AL, et al, AdICoNA, Groups tLS. Relationship between
HAART adherence and adipose tissue alterations. J Acquir Immune
Defic Syndr 2002;31:S140e4.
1051N.D. Shippee et al. / Journal of Clinical Epidemiology 65 (2012) 1041e1051[133] Rasmussen JN, Chong A, Alter DA. Relationship between ad-
herence to evidence-based pharmacotherapy and long-term
mortality after acute myocardial infarction. JAMA 2007;297:
177e86.
[134] Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treat-
ment adherence to the risk of death after myocardial infarction in
women. JAMA 1993;270:742e4.
[135] Mitchell M, Klein R. The sequelae of untreated maternal hypothy-
roidism. Eur J Endocrinol 2004;151:U45e8.
[136] Fenley J, Powers PS, Miller J, Rowland M. Untreated anorexia nerv-
osa: a case study of the medical consequences. Gen Hosp Psychiatry
1990;12:264e70.
[137] Flack JM, Novikov SV, Ferrario CM. Benefits of adherence to anti-
hypertensive drug therapy. Eur Heart J 1996;17:16e20.
[138] Morris AD, Boyle DIR, McMahon AD, Greene SA, MacDonald TM,
Newton RW. Adherence to insulin treatment, glycaemic control, and
ketoacidosis in insulin-dependent diabetes mellitus. Lancet
1997;350:1505e10.
[139] Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA,
Murray FT, Anderson RT. Predictors of medication adherence and
associated health care costs in an older population with type 2 dia-
betes mellitus: a longitudinal cohort study. Clin Ther 2003;
25:2958e71.
[140] Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of
medication adherence on hospitalization risk and healthcare cost.
Med Care 2005;43:521e30.
[141] Pehrsson K, Larsson S, Oden A, Nachemson A. Long-term follow-
up of patients with untreated scoliosis. A study of mortality, causes
of death, and symptoms. Spine 1992;17:1091e6.
[142] Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al.
Influence of obstructive sleep apnea on mortality in patients with
heart failure. J Am Coll Cardiol 2007;49:1625e31.
[143] Bindman AB, Grumbach K, Osmond D, Komaromy M, Vranizan K,
Lurie N, et al. Preventable hospitalizations and access to health care.
JAMA 1995;274:305e11.
[144] Bolen SD, Bricker E, Samuels TA, Yeh HC, Marinopoulos SS,
McGuire M, et al. Factors associated with intensification of oral di-
abetes medications in primary care provider-patient dyads: a cohort
study. Diabetes Care 2009;32:25e31.
[145] Maddox TM, Ross C, Tavel HM, Lyons EE, Tillquist M, Ho PM,
et al. Blood pressure trajectories and associations with treatment in-
tensification, medication adherence, and outcomes among newly di-
agnosed coronary artery disease patients. Circ Cardiovasc Qual
Outcomes 2010;3:347e57.
[146] May C, Finch T, Mair F, Ballini L, Dowrick C, Eccles M, et al. Un-
derstanding the implementation of complex interventions in health
care: the normalization process model. BMC Health Serv Res
2007;7:142.
[147] May C, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S,
et al. Development of a theory of implementation and integration:
Normalization Process Theory. Implement Sci 2009;4:29.
[148] Martin DP, Diehr P, Cheadle A, Madden CW, Patrick DL,
Skillman SM. Health care utilization for the ‘‘newly insured’’:results from the Washington Basic Health Plan. Inquiry 1997;34:
129e42.
[149] Kogut SJ, Andrade SE, Willey C, Larrat EP. Nonadherence as a pre-
dictor of antidiabetic drug therapy intensification (augmentation).
Pharmacoepidemiol Drug Saf 2004;13:591e8.
[150] Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K,
Soumerai SB, et al. Relationship between patient medication adher-
ence and subsequent clinical inertia in type 2 diabetes glycemic
management. Diabetes Care 2007;30:807e12.
[151] Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN,
Masoudi FA, et al. Importance of therapy intensification and medi-
cation nonadherence for blood pressure control in patients with cor-
onary disease. Arch Intern Med 2008;168:271e6.
[152] Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is
this patient taking the treatment as prescribed? JAMA 1993;
269:2779e81.
[153] May C, Montori VM, Mair FS. We need minimally disruptive med-
icine. Br Med J 2009;339:485e7.
[154] Cole AJ, Scott J, Ferrier IN, Eccleston D. Patterns of treatment
resistance in bipolar affective disorder. Acta Psychiatr Scand
1993;88:121e3.
[155] Sturmey P. Secretin is an ineffective treatment for pervasive devel-
opmental disabilities: a review of 15 double-blind randomized con-
trolled trials. Res Dev Disabil 26:87e97.
[156] Vollmer-Conna P, Hickie M, Hadzi-Pavlovic B, Tymms M,
Wakefield M, Dwyer P, et al. Intravenous immunoglobulin is inef-
fective in the treatment of patients with chronic fatigue syndrome.
Am J Med 1997;103:38e43.
[157] Ross CE, Mirowsky J, Pribesh S. Powerlessness and the amplifica-
tion of threat: neighborhood disadvantage, disorder, and mistrust.
Am Sociol Rev 2001;66:568e91.
[158] Weinrath M, Gartrell J. Victimization and fear of crime. Violence
Vict 1996;11:187e97.
[159] May C. Mundane medicine, therapeutic relationships, and the clin-
ical encounter. In: Pescosolido B, Martin JA, Rogers AE, editors.
Handbook of the sociology of health, illness, and healing: blueprint
for the 21st century. New York, NY: Springer; 2011.
[160] Nutting PA, Miller WL, Crabtree BF, Jaen CR, Stewart EE,
Stange KC. Initial lessons from the first national demonstration pro-
ject on practice transformation to a patient-centered medical home.
Ann Fam Med 2009;7:254e60.
[161] Brod M, Skovlund S, Wittrup-Jensen K. Measuring the impact of di-
abetes through patient report of treatment satisfaction, productivity
and symptom experience. Qual Life Res 2006;15:481e91.
[162] Preston SH, Hill ME, Drevenstedt GL. Childhood conditions that
predict survival to advanced ages among African-Americans. Soc
Sci Med 1998;47:1231e46.
[163] Corser W, Holmes-Rovner M, Lein C, Gossain V. A shared
decision-making primary care intervention for type 2 diabetes. Dia-
betes Educ 2007;33:700e8.
[164] Mullan RJ, Montori VM, Shah ND, Christianson TJH, Bryant SC,
Guyatt GH, et al. The diabetes mellitus medication choice decision
aid: a randomized trial. Arch Intern Med 2009;169:1560e8.
